Clinuvel Pharmaceuticals LimitedASX: CUV

Chair address - amendment

· Issued by Clinuvel Pharmaceuticals Limited via ASX

Filed with ASX · · 3 pages · English

On 6ix: 6ix.com/news/chair-address-amendment-1

Watch Clinuvel Pharmaceuticals' latest callClinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings Call · Replay · Aug 27Read the transcript of Clinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings Call

Release

6 November 2026 CLINUVEL has re-released the Chair’s address from this morning’s AGM to correct an error in timing of the start of the CUV107 study. CHAIR’S ADDRESS TO THE 2026 ANNUAL GENERAL MEETING Dear Shareholders, As I stated at the opening of the meeting, I welcome you to the 2026...

Clinuvel Pharmaceuticals Limited on 6ix

Earlier from Clinuvel Pharmaceuticals

Later from Clinuvel Pharmaceuticals

All Clinuvel Pharmaceuticals news releases